Legislative Efforts
Administrative Rule
Rulemaking proceedings begin with a scope statement that is published in the Administrative Register.
The scope statements listed below are from the current legislative session. If you would like to view scope statements published prior to this session you can visit the legislative website here.
You may search for this information by agency, keyword, or by register date on which the rule was first introduced.
SS
121_18
121_18
Controlled Substances Board (CSB) - Scheduling of FDA approved cannabidiol drugs
Relating To: Scheduling of FDA approved cannabidiol drugs
SS 121_18
Clearing House Rules
Add to a FOCUS Subscription
SS 121_18
Clearing House Rules
Add to a FOCUS Subscription
Lobbying Principals
Print| Principal Name | Notified Date | Communication Date | Comments | Supporting Documentation | |
|---|---|---|---|---|---|
| Greenwich Biosciences, Inc. | Notified Date 1/22/2019 | Communication Date N/A | Comments | Supporting Documentation | Position Info |
|
For
Report Date1/22/2019 |
|||||
| Jazz Pharmaceuticals, Inc. and its subsidiaries, including Greenwich Biosciences, Inc. | Notified Date 5/24/2021 | Communication Date N/A | Comments | Supporting Documentation | Position Info |
|
For
Report Date5/24/2021 |
|||||
Lobbying Efforts
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Hours Of Effort On This Matter | 2017 January - June 7.00 |
2017 July - December |
2018 January - June |
2018 July - December |
Total 7.00 |
| Greenwich Biosciences, Inc. | 2017 January - June 7.00 |
2017 July - December |
2018 January - June |
2018 July - December |
Total 7.00 |